(Q44765503)

English

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status

scientific article published in October 2002

Statements

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status (English)
C S Thomson
C J Twelves
E A Mallon
R E Leake
Scottish Cancer Trials Breast Group
Scottish Cancer Therapy Network
1 October 2002
419-429

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit